Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
Clinical trial NCT04241601 · COMPLETED
Trial details
- NCT number
- NCT04241601
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2023-01-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.